Predicate |
Object |
assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_be1cf2420c0361a897c850b4bfe42a8d http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_28e6d9b65902f3f329a2aa3d09ec93a2 http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_a431f1e5f5bd51f2842c97425b320542 |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K51-0453 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K51-0427 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K49-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K51-00 |
filingDate |
2005-09-22-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_552621cd51c5c1c0c80ea0e2786f084f http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b822473c122f63864e4b3f60c510f26b |
publicationDate |
2006-04-06-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
WO-2006036777-A2 |
titleOfInvention |
Diagnosis of diseases associated with cox-2 expression |
abstract |
Derivatives of cyclooxygenase-2 inhibitor compounds are made incorporating a label that can be identified upon administration into the body of a mammal and subsequent binding of the compounds with cyclooxygenase-2 that is overexpressed due to a disease condition such as cancer. |
priorityDate |
2004-09-27-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |